Skip to main content

STERIS plc

corporate_fare Company Profile

STERIS plc

STE·NYSE·Industrial Applications And Services·CIK 0001757898

STERIS plc is a leading global provider of products and services that support patient care, with a focus on infection prevention. The company offers a mix of innovative products and services to healthcare and life science customers worldwide. These include consumable products such as detergents, endoscopy accessories, barrier products, instruments, and tools. Services provided include equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing. STERIS also provides capital equipment like sterilizers, surgical tables, and automated endoscope reprocessors, along with connectivity solutions such as operating room (OR) integration. The company operates and reports financial information across three reportable business segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Previously, there were four segments, but the Dental segment was divested in fiscal 2025 and is now presented as discontinued operations. Historical information has been retrospectively adjusted for comparability. The majority of STERIS's revenues come from healthcare, medical device, and pharmaceutical customers. Growth in these industries is influenced by the global aging population, advancements in healthcare delivery, acceptance of new technologies, government policies, and general economic conditions. Increased demand for medical procedures, including preventive screenings like endoscopies and colonoscopies, and customers' desire for operational efficiency also drive demand for STERIS's products and services.

STERIS plc (NYSE:STE) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors STE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • STERIS Reports Strong FY26: Revenue Hits $5.94B, EPS Jumps 28% to $7.93
  • STERIS Reports Strong FY26 Results, Boosts Share Repurchase Program to $1.0 Billion
  • STERIS Q4 Profit Jumps 51% to $220M as Revenue Climbs 7.3%
  • STERIS Reports Strong FY26 Results, Issues Positive FY27 Guidance, and Authorizes $1B Share Buyback
  • STERIS Reports Strong Q3 Results, Maintains FY26 Outlook Despite Increased Tariffs

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$5.94B
Net Income
$782.3M
Diluted EPS
$7.93
Op. Cash Flow
$1.34B
Free Cash Flow
$972.4M
Gross Profit
$2.63B
Operating Income
$1.1B
Cash & Equivalents
$439.6M
Total Debt
$1.93B
Debt / Equity
0.27×
Net Margin
13.2%
Shares Outstanding
97.8M sh
Source: 10-K · filed 2026-05-29 · accession 0001628280-26-039136
Browse all tickers starting with S →
$207.56
52-week range · as of 2026-05-29 $195.14 – $269.44
Market cap
$20.26B
Volume
628.3K (0.7× avg)
3-mo avg 840.8K
Live data · 2026-06-14 03:03 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed STE - Latest Insights

STE
May 29, 2026, 4:25 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $212.73
Real-time Price: $207.56 info
Change: -$5.17 (-2%) info
Market Cap: $20.258B info
STE
May 29, 2026, 4:04 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $212.73
Real-time Price: $207.56 info
Change: -$5.17 (-2%) info
Market Cap: $20.258B info
STE
May 11, 2026, 6:08 PM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $204.99
Real-time Price: $207.56 info
Change: +$2.57 (+1%) info
Market Cap: $20.258B info
STE
May 11, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $210.00
Real-time Price: $207.56 info
Change: -$2.44 (-1%) info
Market Cap: $20.258B info
STE
Feb 04, 2026, 4:32 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $257.72
Real-time Price: $207.56 info
Change: -$50.16 (-19%) info
Market Cap: $20.258B info